BACE1 and Alzheimer disease: In contrast, another study reported no evidence that overexpression or deletion of PCSK9 regulates BACE1 levels and/or APP processing in the mouse brain, suggesting that PCSK9 effect on AD may be tissue-specific or mediated by other biochemical factors [77].